Steven Ortega
Plus aucun poste en cours
Fortune : 376 747 $ au 31/03/2024
Provenance du réseau au premier degré de Steven Ortega
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Steven Ortega via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
BNY Mellon Investment Adviser, Inc.
BNY Mellon Investment Adviser, Inc. Investment ManagersFinance BNY Mellon Investment Adviser, Inc. (BNYMIA) is a SEC-registered investment advisor headquartered in New York City. The firm was founded in 1951 and formerly known as The Dreyfus Corp. They are a wholly-owned subsidiary of MBC Investments Corp., ultimately held by The Bank of New York Mellon Corp. (NYSE: BK). BNYMIA serves as an investment advisor to mutual funds, such as the BNY Mellon Family of Funds and The BNY Mellon Funds Trust, and as sub-investment advisor to non-affiliated mutual funds. Formed in 2009, Dreyfus Cash Investment Strategies (Dreyfus) is a division of the BNYMIA that offers money market strategies to US and non-US institutional investors. | Investment Managers | Portfolio Manager-Equities | |
Goldman Sachs Asset Management LP
Goldman Sachs Asset Management LP Investment ManagersFinance Goldman Sachs Asset Management LP (GSAMLP) is a SEC-registered investment advisor headquartered in New York City. The firm is a wholly owned subsidiary of GSAM Holdings LLC, and their ultimate parent is Goldman Sachs Group, Inc. (NYSE: GS). Founded in 1988, GSAMLP provides investment solutions to a range of individual and institutional investors worldwide. | Investment Managers | Portfolio Manager-Equities | |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Financial Conglomerates | Corporate Officer/Principal | |
University of Madras | College/University | Undergraduate Degree | |
Yeshiva University | College/University | Doctorate Degree | |
Goldensource (DE)
Goldensource (DE) Packaged SoftwareTechnology Services GoldenSource Corp. provides enterprise data management software. The firm provides preconfigured connectivity and data integration interface which applies into EDM applications. It also provides solutions for the derivatives and fixed income markets. The company was founded in 1984 and is headquartered in New York, NY. | Packaged Software | Corporate Officer/Principal | |
Albert Einstein College of Medicine, Inc. | College/University | Doctorate Degree | |
Ramco Systems Corp.
Ramco Systems Corp. Packaged SoftwareTechnology Services Ramco Systems Corp. designs and develops enterprise software and services. The company is headquartered in Lawrenceville, NJ. | Packaged Software | Corporate Officer/Principal | |
ALLERGAN PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Columbia Business School | College/University | Masters Business Admin | |
BioXcel Corp.
BioXcel Corp. Data Processing ServicesTechnology Services BioXcel Corp. is a biopharmaceutical company based in Branford, CT that utilizes advanced technologies such as AI to develop transformative medicines at unprecedented speed in multiple therapeutic areas with high unmet needs. BioXcel's AI-enabled platform, EvolverAI, helps reduce development costs and accelerates the drug development timelines for a technologically-enabled, fast and efficient drug discovery process. The private company's family of companies includes BioXcel Therapeutics, Inc., which is a biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing AI and its approaches. BioXcel is deeply involved in creating breakthroughs in various categories of diseases. The company was founded by Vimal D. Mehta and Krishnan Nandabalan, with Vimal D. Mehta serving as the CEO since incorporation. | Data Processing Services | Director of Finance/CFO | |
BIOXCEL THERAPEUTICS, INC. | Biotechnology | Comptroller/Controller/Auditor |
Statistiques
Internationale
Etats-Unis | 13 |
Inde | 2 |
Irlande | 2 |
Sectorielle
Finance | 5 |
Consumer Services | 5 |
Technology Services | 4 |
Health Technology | 3 |
Commercial Services | 2 |
Opérationnelle
Director of Finance/CFO | 5 |
Corporate Officer/Principal | 4 |
Comptroller/Controller/Auditor | 4 |
Portfolio Manager-Equities | 3 |
Doctorate Degree | 2 |
Relations les plus connectées
- Bourse
- Insiders
- Steven Ortega
- Connexions Sociétés